This method simplifies targeted tissue analysis for tissue proteomic mapping compared to molecular histology
(3) or proteohistography (4).
Bruker's market leading, top of the range product has been significantly enhanced to offer both increased analytical power and entirely new functionality, extending the applications envelope of MALDI TOF/TOF far beyond the conventional concepts of what's possible in molecular histology, glycoprotein and biopharmaceuticals analysis.
While biomarker discovery in large tissue-sample cohorts can now be achieved at record high speed, Bruker has also significantly extended the discovery potential of Molecular Histology with the new ImageID[TM] workflow.
In addition, as recently announced, the integration of the Carl Zeiss' MIRAX Virtual Slide Scanner has enabled revolutionary advances in non-targeted molecular histology
with high spatial resolution (research use only).
CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY Background Molecular Histology
Market Analysis HPV Testing CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY Overview HIV/AIDS Hepatitis Sexually Transmitted Diseases Hospital Acquired Infections Respiratory Tract Infections Tuberculosis Blood Culture Miscellaneous Mass Spectrometry
Carl Zeiss' MIRAX Virtual Slide Scanner and Bruker's MALDI Molecular Imager(TM) now enable non-targeted molecular histology
with high spatial resolution in an integrated solution (research use only) for biological tissue research and clinical pathology research.
Point of View CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC Background Cancer gets more personal Pathogen sequencing CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER Background Blood-based analyses Circulating Tumor Cells CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY Background CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE Background Coagulation Market Analysis CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY Background Molecular Histology
Market Analysis HPV Testing CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY Overview HIV/AIDS Hepatitis Sexually Transmitted Diseases Hospital Acquired Infections Respiratory Tract Infections
Integration of MIRAX Virtual Slide Scanner from Carl Zeiss into Bruker's MALDI Molecular Imager[TM] Enables Non-Targeted Molecular Histology -- Combined Solution to be Introduced at German Pathology Society (DGP) Meeting in June 2009
The goal of the Bruker-Carl Zeiss collaboration is to advance molecular histology research by providing an integrated solution (for research use only) for biological tissue research and pathology that adds non-targeted molecular information and 'molecular contrast' to histology.
from tumors) can be generated and used for biomarker discovery and molecular histology.
The complete Bruker solution comprises the new ImagePrep[TM] device for automated high-resolution matrix application on tissue, the unique SmartBeam[TM] laser technology and the proprietary ClassImaging[TM] algorithm for tissue classification and biomarker detection, molecular histology
as well as imaging of drug and metabolite distributions in drug development.
CHAPTER SEVENTEEN: COMPANY PROFILES: TOP TIER IVD COMPANIES' MOLECULAR BUSINESSES Abbott Diagnostics Recent Revenue History HLA Molecular Histology
Companion Tests Molecular Diagnostics Infectious Diseases - Molecular IntelligentMDx Alliance PLEX-ID Alere Recent Revenue History ARKRAY Beckman Coulter Inc.